Notable 52-Week Highs and Lows of the Day 01/17: (PFE) (BVSN) (KFT) High; (KGC) (CHK) (CBRX) Low

This report is an intraday check of some of the more notable stocks that have hit a 52-week high or low so far today.

52-Week High:

• Pfizer Inc. (NYSE: PFE) high of $22.17. Earlier Tuesday, Medivation (Nasdaq: MDVN) and Pfizer (NYSE: PFE) announced results from the CONCERT trial, which is a Phase 3 trial that evaluated dimebon (latrepirdine) when added to ongoing treatment with donepezil HCL tablets in patients with mild-to-moderate Alzheimer's disease.
  
  Dimebon did not achieve statistically significant results for either of the two co-primary endpoints, the Alzheimer's Disease Assessment Scale.
  
  Pfizer could still be moving higher on overall sentiment today, as well as word late-Friday that Nestle and Danone were said to have submitted bids for Pfizer's baby food unit.
  
  
• BroadVision, Inc. (Nasdaq: BVSN) high of $23.00. BroadVision moving 30.9 percent better on the session following reports that its Clearvale was selected to provide the social business platform for London's Digital Summit.
  
  
• Kraft Foods Inc. (NYSE: KFT) high of $38.53. Kraft moving higher following an updated 2011 outlook. According to the release: "Net revenue for full year 2011 is expected to have grown approximately 10 percent. Organic Net Revenue is expected to increase approximately 6.5 percent, compared to a previous outlook of at least 6 percent, driven by mid-single-digit organic growth in North America and Europe, and double-digit organic growth in Developing Markets. The Street forecasts total sales of $14.85 billion for Q4 and $54.38 billion for the full year.
  
  Diluted earnings per share are expected to be at least $1.95. Operating EPS, which excludes acquisition-related costs, Integration Program costs, and costs related to the spin-off of the North American Grocery business, is expected to be at least $2.28, including a negative $0.01 impact from currency in the fourth quarter. The previous outlook for Operating EPS was at least $2.27 excluding any potential impact from currency in the fourth quarter. The Street forecasts EPS of $0.57 for Q4 and $2.27 for FY11."

52-Week Low:

• Kinross Gold Corporation (NYSE: KGC) low of $10.44. Lower following 2011 production results, and 2012 outlook. According to Kinross, "capital expenditures in 2012 are expected to be approximately $1.3 billion related to growth projects, primarily for Tasiast. The 2012 forecast for exploration and business development expenses is approximately $255 million, of which $185 million is forecast for exploration. Capitalized exploration is forecast to be $35 million, for total 2012 forecast exploration expenditures of $220 million."
  
  For more color from the release, click here.
  
  
• Chesapeake Energy Corporation (NYSE: CHK) low of $20.80. Chesapeake continues lower as nat gas prices continue to fall on warmer-than-usual weather across the Midwest and Eastern U.S. Shares moved an additional 2.9 percent to the new mark Tuesday.
  
  
• Columbia Labs (Nasdaq: CBRX) low of $1.01. Columbia Labs dropped over 58 percent on news that the FDA believes its preterm birth gel is not effective.
  
  
• R.R. Donnelley & Sons Co. (NYSE: RRD) low of $12.08. R. R. Donnelley said it expects full-year 2011 free cash flow to be in the range of $650 million to $700 million, an increase from the previous guidance that called for free cash flow of approximately $600 million. Revenue is expected to be $10.6 billion, non-GAAP operating margin is expected to be 6.6 percent to 6.7 percent, non-GAAP effective tax rate is expected to be 23 percent to 24 percent and fully-diluted weighted average share count is expected to be 196 million to 197 million. The Street sees revs of $10.61 billion.

---

Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!

You May Also Be Interested In

• UPDATE: Auriga Starts Teva Pharma (TEVA) at Hold; Sidelined Until New CEO Is Convincing
• UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
• UPDATE: Ralph Lauren Corp (RL) Reports Solid Q4 Results; Guides FY13 Sales

Create E-mail Alert Related Categories

Special Reports

Related Entities

Earnings

Comments

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?

Follow StreetInsider.com On Twitter